NCT05468788

Brief Summary

Investigators are building a program that uses improvisation to teach kids and teens with medical issues healthy ways to cope. Medical issues have been linked to anxiety and depression. Doing theatre can prevent these complications. Participants will meet in groups of about ten for ten weeks to do improvisation that is fun and supportive. Participants will meet with a study team member before the program starts, after the program ends, six months after the program ends, and twelve months after the program ends. At these visits, participants will be screened for anxiety, depression, quality of life, and will be given a short interview.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 24, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 12, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 21, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

August 12, 2024

Status Verified

August 1, 2024

Enrollment Period

2.3 years

First QC Date

July 12, 2022

Last Update Submit

August 8, 2024

Conditions

Outcome Measures

Primary Outcomes (18)

  • Anxiety and Depression

    Anxiety and Depression as evaluated by the Revised Children's Anxiety and Depression Scale; Scored 0-30; higher score indicates worse outcome

    Baseline to 10 weeks

  • Anxiety and Depression

    Anxiety and Depression as evaluated by the Revised Children's Anxiety and Depression Scale; Scored 0-30; higher score indicates worse outcome

    Baseline to 6 months

  • Anxiety and Depression

    Anxiety and Depression as evaluated by the Revised Children's Anxiety and Depression Scale; Scored 0-30; higher score indicates worse outcome

    Baseline to 12 months

  • Disease-Related Quality of Life

    Disease-Related Quality of Life as evaluated by Qualitative Interview

    Baseline to 10 weeks

  • Disease-Related Quality of Life

    Disease-Related Quality of Life as evaluated by Qualitative Interview

    Baseline to 6 months

  • Disease-Related Quality of Life

    Disease-Related Quality of Life as evaluated by Qualitative Interview

    Baseline to 12 months

  • Disease-Related Quality of Life

    Disease-Related Quality of Life as evaluated by Pediatric Quality of Life Inventory; Scored 0-100; higher score indicates better outcome

    Baseline to 10 weeks

  • Disease-Related Quality of Life

    Disease-Related Quality of Life as evaluated by Pediatric Quality of Life Inventory; Scored 0-100; higher score indicates better outcome

    Baseline to 6 months

  • Disease-Related Quality of Life

    Disease-Related Quality of Life as evaluated by Pediatric Quality of Life Inventory; Scored 0-100; higher score indicates better outcome

    Baseline to 12 months

  • Knowledge and Utilization of Coping Strategies

    Knowledge and Utilization of Coping Strategies as evaluated by Qualitative Interview

    Baseline to 10 weeks

  • Knowledge and Utilization of Coping Strategies

    Knowledge and Utilization of Coping Strategies as evaluated by Qualitative Interview

    Baseline to 6 months

  • Knowledge and Utilization of Coping Strategies

    Knowledge and Utilization of Coping Strategies as evaluated by Qualitative Interview

    Baseline to 12 months

  • Knowledge and Utilization of Coping Strategies

    Knowledge and Utilization of Coping Strategies as evaluated by KidCope Checklist; Scored 0-120; higher score indicates better outcome

    Baseline to 10 weeks

  • Knowledge and Utilization of Coping Strategies

    Knowledge and Utilization of Coping Strategies as evaluated by KidCope Checklist; Scored 0-120; higher score indicates better outcome

    Baseline to 6 months

  • Knowledge and Utilization of Coping Strategies

    Knowledge and Utilization of Coping Strategies as evaluated by KidCope Checklist; Scored 0-120; higher score indicates better outcome

    Baseline to 12 months

  • Empathy

    Empathy as evaluated by Qualitative Interview

    Baseline to 10 weeks

  • Empathy

    Empathy as evaluated by Qualitative Interview

    Baseline to 6 months

  • Empathy

    Empathy as evaluated by Qualitative Interview

    Baseline to 12 months

Study Arms (2)

Integrative Community Therapy (ICT) Intervention Arm

EXPERIMENTAL

Participants will perform scenes related to having a chronic medical condition and they will be guided through conversations about their feelings and coping methods.

Behavioral: Intervention: Integrative Community Therapy-based Psychodrama

Improvisational Theatre Arm

SHAM COMPARATOR

Participants will perform generic improvisational theatre with no instruction on feelings or coping methods.

Behavioral: Control: Improvisational Theatre

Interventions

Participants produce theatre scenes depicting issues that they have experienced. Group leaders then use a guide to facilitate a discussion of participants' feelings, coping strategies, and sharing of local knowledge.

Also known as: Intervention: ICT-based Psychodrama
Integrative Community Therapy (ICT) Intervention Arm

Participants play improvisational theatre games.

Improvisational Theatre Arm

Eligibility Criteria

Age5 Years - 19 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Identify as having a CMC
  • In grades kindergarten to 12th grade during the year recruited for the study
  • years of age and ≤ 19 years of age at the start of the intervention
  • Able and willing to participate in improvisational theatre in spoken English
  • Able to understand and answer standard questionnaires used for evaluation in English (with or without accommodation)

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger Primary Care South Wilkes-Barre

Wilkes-Barre, Pennsylvania, 18702, United States

Location

Related Publications (16)

  • Young KS, Sandman CF, Craske MG. Positive and Negative Emotion Regulation in Adolescence: Links to Anxiety and Depression. Brain Sci. 2019 Mar 29;9(4):76. doi: 10.3390/brainsci9040076.

    PMID: 30934877BACKGROUND
  • Jones LC, Mrug S, Elliott MN, Toomey SL, Tortolero S, Schuster MA. Chronic Physical Health Conditions and Emotional Problems From Early Adolescence Through Midadolescence. Acad Pediatr. 2017 Aug;17(6):649-655. doi: 10.1016/j.acap.2017.02.002. Epub 2017 Feb 12.

    PMID: 28215656BACKGROUND
  • Cobham VE, Hickling A, Kimball H, Thomas HJ, Scott JG, Middeldorp CM. Systematic Review: Anxiety in Children and Adolescents With Chronic Medical Conditions. J Am Acad Child Adolesc Psychiatry. 2020 May;59(5):595-618. doi: 10.1016/j.jaac.2019.10.010. Epub 2019 Oct 30.

    PMID: 31676391BACKGROUND
  • Compas BE, Jaser SS, Dunn MJ, Rodriguez EM. Coping with chronic illness in childhood and adolescence. Annu Rev Clin Psychol. 2012;8:455-80. doi: 10.1146/annurev-clinpsy-032511-143108. Epub 2011 Dec 20.

    PMID: 22224836BACKGROUND
  • Greenberg MT, Weissberg RP, O'Brien MU, Zins JE, Fredericks L, Resnik H, Elias MJ. Enhancing school-based prevention and youth development through coordinated social, emotional, and academic learning. Am Psychol. 2003 Jun-Jul;58(6-7):466-74. doi: 10.1037/0003-066x.58.6-7.466.

    PMID: 12971193BACKGROUND
  • Hersov L. Psychotherapy for Children and Adolescents. Evidence-based Treatments and Case Examples. Child Adolesc Ment Health. 2006 May;11(2):124-125. doi: 10.1111/j.1475-3588.2006.00399_5.x. No abstract available.

    PMID: 32811094BACKGROUND
  • Feniger-Schaal R, Koren-Karie N. Using Drama Therapy to Enhance Maternal Insightfulness and Reduce Children's Behavior Problems. Front Psychol. 2021 Jan 20;11:586630. doi: 10.3389/fpsyg.2020.586630. eCollection 2020.

    PMID: 33551907BACKGROUND
  • Blacker J, Watson A, Beech AR. A combined drama-based and CBT approach to working with self-reported anger aggression. Crim Behav Ment Health. 2008;18(2):129-37. doi: 10.1002/cbm.686.

    PMID: 18383198BACKGROUND
  • Joronen K, Hakamies A, Astedt-Kurki P. Children's experiences of a drama programme in social and emotional learning. Scand J Caring Sci. 2011 Dec;25(4):671-8. doi: 10.1111/j.1471-6712.2011.00877.x. Epub 2011 Mar 1.

    PMID: 21362006BACKGROUND
  • Daykin N, Orme J, Evans D, Salmon D, McEachran M, Brain S. The impact of participation in performing arts on adolescent health and behaviour: a systematic review of the literature. J Health Psychol. 2008 Mar;13(2):251-64. doi: 10.1177/1359105307086699.

    PMID: 18375630BACKGROUND
  • Joronen K, Rankin SH, Astedt-Kurki P. School-based drama interventions in health promotion for children and adolescents: systematic review. J Adv Nurs. 2008 Jul;63(2):116-31. doi: 10.1111/j.1365-2648.2008.04634.x.

    PMID: 18537845BACKGROUND
  • Miranda NA, Berardinelli LM, Saboia VM, Brito ID, Santos RD. Interdisciplinary care praxis in groups of people living with fibromyalgia. Rev Bras Enferm. 2016 Nov-Dec;69(6):1115-1123. doi: 10.1590/0034-7167-2016-0279. English, Portuguese.

    PMID: 27925088BACKGROUND
  • Weigensberg MJ, Vigen C, Sequeira P, Spruijt-Metz D, Juarez M, Florindez D, Provisor J, Peters A, Pyatak EA. Diabetes Empowerment Council: Integrative Pilot Intervention for Transitioning Young Adults With Type 1 Diabetes. Glob Adv Health Med. 2018 Mar 8;7:2164956118761808. doi: 10.1177/2164956118761808. eCollection 2018.

    PMID: 29552422BACKGROUND
  • Chorpita BF, Yim L, Moffitt C, Umemoto LA, Francis SE. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther. 2000 Aug;38(8):835-55. doi: 10.1016/s0005-7967(99)00130-8.

    PMID: 10937431BACKGROUND
  • Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001 Aug;39(8):800-12. doi: 10.1097/00005650-200108000-00006.

    PMID: 11468499BACKGROUND
  • Spirito A, Stark LJ, Williams C. Development of a brief coping checklist for use with pediatric populations. J Pediatr Psychol. 1988 Dec;13(4):555-74. doi: 10.1093/jpepsy/13.4.555. No abstract available.

    PMID: 3216277BACKGROUND

MeSH Terms

Conditions

Chronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Karen A Ephlin, MD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participants will not know which group they are in, as they will not be familiar with the particular procedure of the intervention being studied
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: One group will receive a new behavioral intervention; the other group will receive improvisational theatre alone
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2022

First Posted

July 21, 2022

Study Start

May 24, 2022

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

August 12, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations